Private insurers have turned the Medicare Advantage program into a data gold mine, using detailed medical records to inflate how sick their members look on paper and, in turn, how much the government pays them. The result is a system where corporate profits swell while taxpayers shoulder billions in questionable costs. At the center of this storm is UnitedHealth Group, whose use of Medicare data has drawn scrutiny from investigators, lawmakers, and regulators, and whose tactics are increasingly seen as a warning sign for the entire privatized Medicare model.
Behind the technical language of “risk scores” and “coding intensity” is a simple reality: every exaggerated diagnosis translates into higher bills for the public. As evidence mounts that plans have been paid for conditions patients never had or that were added long after a visit, the stakes are no longer abstract. They are measured in tens of billions of dollars, in the integrity of Medicare, and in whether older Americans can trust that their health data is being used to care for them rather than to game the system.
How Medicare Advantage became a data-driven cash machine
Medicare Advantage was built on a straightforward idea: pay private plans more for sicker enrollees so they have the resources to manage complex care. To do that, the federal government relies on a risk adjustment formula that turns diagnoses in Medicare records into a numerical score, which then drives monthly payments to insurers. The Centers for Medicare & Medicaid Services, or CMS, oversees this formula and the flow of public dollars, but the raw material is the intimate clinical information that patients share with their doctors.
That data has become the foundation of a lucrative business model. A detailed review of UnitedHealth’s operations found that the company used Medicare records to identify potential diagnoses that could raise risk scores, then pushed to add those codes to patient charts, a pattern described in a report titled Insurer Mined Medicare. The same pattern has surfaced across the industry, with investigators finding that plans were paid billions for diseases a Patient never actually had, based on an examination of Medicare data under a federal research agreement.
UnitedHealth’s aggressive tactics and mounting scrutiny
UnitedHealth Group sits at the center of this controversy because of its scale and sophistication. The company is the dominant player in Medicare Advantage, and a Senate inquiry found that it used “aggressive strategies” to seek out diagnoses that would boost federal payments. Staffers for Sen. Chuck Grassley, the Republican from Iowa, reported that UnitedHealth “aggressively” gamed Medicare Advantage by leveraging its data systems and reach in the privatized Medicare program, according to a detailed Senate investigation. Another analysis framed the issue under the heading “Scale Matters,” noting that UnitedHealth’s dominance, with 7.8 m Medicare Advantage members, gives it unique leverage to shape how diagnoses are captured and billed.
Federal law enforcement has taken notice. Justice Department prosecutors have interviewed former employees about company practices that boosted federal payments, part of a broader criminal and civil review of UnitedHealth’s Medicare billing, according to Justice Department inquiries described by reporter Chri. A health-care strategist, Jared Holz of Mizuho Securities, told clients that the announcement of a federal probe into UnitedHealth’s Medicare billing was “not shocking,” given how the company’s growth has come under federal scrutiny. UnitedHealth, for its part, insists that its programs meet the highest standards and that critics are misreading the data, a point the company pressed in a statement responding to a July article from Wall Street Journal.
Billions in overpayments and the taxpayer tab
The financial stakes of this coding arms race are staggering. A report circulated by advocates for older Americans estimated that privately run, government funded Medicare Advantage plans are overcharging U.S. taxpayers by tens of billions of dollars each year, with one analysis pegging the excess at Wednesday as the day a key estimate of $76 billion in extra charges was released. Another review of the program’s finances warned that Medicare Advantage fraud and abuse could reach a total of $76 billion in 2026, a figure that underscores how much of Medicare’s budget is now tied up in private plan payments.
Investigative work with Medicare data has shown how those overpayments materialize. Researchers who examined claims under a federal agreement found that Medicare Advantage plans were paid billions for conditions that a Patient never had, or that were added long after a visit, often through home assessments or chart reviews. Another analysis of home visit programs concluded that Medicare paid insurers billions in extra payments tied to questionable diagnoses, prompting industry groups to complain that critics were taking a “misleading, narrow, and incomplete view” of risk adjustment data, a phrase that appeared in a Medicare focused critique.
Kaiser’s $556 million warning shot
UnitedHealth is not the only giant under the microscope. Affiliates of Kaiser Permanente, an integrated healthcare consortium headquartered in Oakland, California, agreed to pay $556 million to resolve allegations that they violated the False Claims Act by submitting inaccurate diagnosis codes to obtain higher payments from the government. The Justice Department said the case involved Medicare Advantage risk adjustment practices that overstated how sick enrollees were, turning routine chart reviews into a revenue engine. The settlement, which the Justice Department cast as one of the largest of its kind, signaled that prosecutors see diagnosis inflation as a form of fraud, not just aggressive billing.
Additional reporting on the Kaiser case described how some health plans allegedly added diagnoses to patient charts months after visits, without clear evidence that clinicians had treated or even discussed those conditions, behavior that The Justice Department said distorted Medicare Advantage payments. Kaiser has emphasized its commitment to compliance and quality, pointing to its integrated model and the mission of Kaiser Permanente to provide coordinated care. Yet the sheer size of the $556 million settlement, and the fact that it involved sophisticated electronic record systems, underscores how easily large organizations can turn data into a tool for maximizing revenue rather than improving outcomes.
Regulators, audits, and the fight to rein in abuse
Regulators are now racing to catch up with an industry that has spent years perfecting its coding playbook. Under President Donald Trump, the administration signaled a tougher stance on Medicare Advantage audits, with CMS announcing its intent “to crush[] fraud, waste, and abuse across the Medicare program” and to strengthen oversight of plan payments, according to guidance that described how On May 21, 2025, the Centers for Medicare & Medicaid Services would expand aggressive Medicare Advantage plan audits. That same document detailed how CMS planned to respond to concerns from the Medicare Payment Advisory Commission about coding intensity and overpayments.
Lawmakers have added pressure of their own. A new Senate report alleged that UnitedHealth Group used risk adjustment policies in Medicare Adva that aggressively sought diagnoses, including through home assessments and chart reviews that allowed it to capture more conditions. Another summary of the same findings emphasized that Scale Matters when a company with millions of members can standardize these tactics across the country. UnitedHealth has countered that critics are cherry picking information and that its UnitedHealth Group programs deliver high quality care, a message it reinforced in a corporate statement that argued Today’s media coverage relies on flawed analyses.
More From The Daily Overview
*This article was researched with the help of AI, with human editors creating the final content.
Nathaniel Cross focuses on retirement planning, employer benefits, and long-term income security. His writing covers pensions, social programs, investment vehicles, and strategies designed to protect financial independence later in life. At The Daily Overview, Nathaniel provides practical insight to help readers plan with confidence and foresight.
